Αποτελέσματα Αναζήτησης
(COVID-19): A living guideline" aims to provide users with the latest evidence-based recommendations for infection prevention and control in the context of COVID-19 in health care and community settings. The WHO living guidance is separated into two parts: 1) IPC in health
25 Αυγ 2020 · SARS-CoV-2 infection may be asymptomatic or it may cause a wide spectrum of symptoms, such as mild symptoms of upper respiratory tract infection and life-threatening sepsis. COVID-19 first emerged in December 2019, when a cluster of patients with pneumonia of unknown cause was recognized in Wuhan, China.
8 Μαρ 2021 · We did a systematic review and meta-analysis to summarise serological surveys for SARS-CoV-2 infections in humans; to comprehensively evaluate the study designs, laboratory methods, and outcome interpretations for each included serological study; and to estimate the risk of infections by populations with different presumed levels of exposure to ...
17 Ιουν 2021 · Monoclonal Antibodies for Treating SARS-CoV-2 Infection. Monoclonal antibodies (mAbs) can be obtained from laboratory preparation or by COVID-19 patients. Numerous mAbs are approved by the FDA to treat different disorders such as cancer .
27 Οκτ 2021 · have a history of exposure to individuals with SARS-CoV-2 infection and who are at high risk of progression to serious disease if they acquire the infection. • The clinical trial data that support these recommendations are summarized in this section.
16 Αυγ 2021 · Persistent SARS-CoV-2 infection can occur in certain immunocompromised people, such as those with primary immunodeficiency or recipients of immunosuppressive therapy (eg, B cell-depleting anti-CD20 treatment or chimeric antigen receptor T-cell therapy following bone marrow transplantation).
9 Ιουλ 2020 · This scientific brief provides an overview of the modes of transmission of SARS-CoV-2, what is known about when infected people transmit the virus, and the implications for infection prevention and control precautions within and outside health facilities. This scientific brief is not a systematic review.
